Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Hengyi Pharmaceutical is a Chinese pharmaceutical company based in Tianjin that specializes in the production and distribution of chemical drug products. The company primarily focuses on oral solid dosage forms, including tablets and capsules, with a strong emphasis on therapeutic areas such as metabolic diseases, cardiovascular health, and gastrointestinal disorders. As a key manufacturing unit within the Tianjin Pharmaceutical Group (TJPH), it operates modern GMP-certified facilities to supply essential generic medicines to the domestic market. Its product portfolio includes widely used treatments for chronic conditions like diabetes and hypertension, positioning it as a reliable provider of high-quality generic pharmaceuticals in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Hengyi Pharmaceutical.